A Singapore company imports a pharmaceutical product from an overseas manufacturer and supplies it to hospitals and clinics here. A batch later turns out to be contaminated. Patients are harmed. The manufacturer is overseas. Claims land on the Singapore importer.
The importer's first response is usually the same: we did not make it, so why are we responsible?
Under Singapore law, that question has a clear answer. And it is not the one most importers expect.
Why the importer carries liability even without manufacturing the product
In Singapore, therapeutic products, which is the regulatory term for medicines, vaccines, and similar health products, are regulated under the Health Products Act 2007 (HPA). Any company that imports or distributes therapeutic products must hold a licence from the Health Sciences Authority (HSA) before it can do so.
Holding that licence comes with responsibility. The HSA's position is direct: as a licensed dealer, you are responsible for the safety, quality, and efficacy of the therapeutic products you bring into Singapore. That responsibility belongs to you as the importer, regardless of whether you manufactured the product.
This is not a technicality. It reflects the logic of how product regulation works. The patient or the hospital in Singapore dealt with you, not with a factory overseas. You are the party in the Singapore supply chain. You are the party HSA holds accountable.
When something goes wrong with a therapeutic product in the Singapore market, claims and regulatory scrutiny follow the supply chain to the licensed dealer, which means they follow you.
The three ways liability can arise
Product liability for therapeutic product importers and distributors in Singapore does not come from a single law. It can arise from three directions at the same time.
Negligence. Under Singapore common law, every party in a supply chain owes a duty of care to the end user. As an importer, your duty of care includes choosing reputable suppliers, verifying product quality, maintaining proper storage conditions, and staying across post-market safety information. A failure in any of these can give rise to a claim, even if the physical defect originated at the factory.
Contract. Under section 14 of the Sale of Goods Act 1979, as applied in Singapore, every sale of goods carries an implied legal promise that the goods are of satisfactory quality and fit for their intended purpose. A hospital or clinic that buys a therapeutic product from you and finds it defective has a contractual claim against you. This applies regardless of where in the supply chain the defect started.
Regulation. The Health Products Act itself creates obligations and consequences. If you supply a product that does not comply with the HPA's requirements, you face both regulatory enforcement action and potential civil liability. These can run simultaneously.
The key takeaway is that your liability as an importer or distributor does not depend on whether you caused the defect. It depends on your position in the supply chain and your responsibility for the product's quality in Singapore.
What you are required to do under the HPA
The Health Products Act places specific obligations on licensed dealers when something goes wrong with a product.
If you become aware of any defect in a therapeutic product you supply, or any adverse effect that can arise from its use, you must notify HSA. If HSA decides a recall is necessary, the dealer must notify HSA at least 24 hours before initiating the recall. Failure to comply with a recall notice issued under the HPA is a statutory offence.
On 28 January 2026, HSA issued Version 3 of its guidance on product defect reporting and recall procedures. The updated guidance makes clear that responsibility for reporting and recall is distributed across the entire supply chain, not just the manufacturer. That means importers, distributors, wholesalers, and even logistic providers can all have obligations when a product needs to be recalled.
This is worth sitting with for a moment. Even if your role is purely distribution, you may have reporting obligations the moment you become aware of a product problem.
What product liability insurance covers
Product liability insurance covers your legal liability to third parties if a product you supplied causes bodily injury or property damage. For a therapeutic product importer or distributor, the people who may bring a claim include patients who suffered harm, hospitals and clinics that administered the affected product and face their own downstream claims, and other parties in the distribution chain.
The policy covers your legal defence costs from the moment a claim arrives, and any damages or settlement amounts if the claim succeeds, up to the policy limit.
Two things are particularly important to confirm when arranging product liability cover for a therapeutic products business.
First, does the policy cover defects that originated with the overseas manufacturer? Many product liability policies do extend to upstream manufacturing defects, but this needs to be specifically confirmed rather than assumed. If the policy excludes claims arising from manufacturing defects you had no part in causing, that is a significant gap for an importer.
Second, does the policy's geographic scope reflect where you actually supply products? If your distribution network extends beyond Singapore into Malaysia, Indonesia, Thailand, or other ASEAN markets, the policy needs to cover claims arising from products supplied in those markets too.
You can read more about our product liability cover on the products page.
The recall cost gap that most importers miss
Product liability insurance responds to third-party claims. It does not cover the direct operational costs of conducting a recall.
When a recall happens, whether HSA requires it or you initiate it voluntarily, there are immediate costs: notifying every hospital, clinic, and pharmacy that received the product, arranging the logistics of getting the product back, storing and disposing of recalled stock, and managing all the communications and paperwork. For a distributor whose products have been supplied to dozens of healthcare facilities, a single recall event can be expensive to execute, entirely apart from any patient claims.
Product recall insurance is a separate cover designed specifically for these first-party recall costs. Given that HSA's January 2026 updated guidance has clarified recall obligations across the full supply chain, it is worth checking whether your current programme includes recall cover alongside your product liability policy.
When professional indemnity also becomes relevant
Some therapeutic product distributors do more than simply supply the product. They provide product information to healthcare professionals, offer dosage guidance, give storage and handling advice, or run training sessions on how to administer a product.
When that kind of advice leads to harm, the liability that arises is different in nature from a product defect claim. It is a professional liability claim, arising from something you said or recommended rather than something wrong with the product itself. Standard product liability policies are not designed to cover this.
If your business includes providing information, guidance, or training to healthcare customers, professional indemnity insurance is a separate consideration from your product liability cover.
You can read more about our professional indemnity cover on the products page.
Four questions to ask about your current insurance
For any Singapore company that imports or distributes therapeutic products, these four questions are worth going through before the next renewal.
Does the product liability policy cover defects that originated with the overseas manufacturer, and does it extend to all the markets where you supply products?
Does your programme include specific product recall cover? Product liability and product recall are separate covers addressing different costs. Many distributors have one without the other.
If you provide product information, dosage guidance, or training to healthcare customers, does your programme include professional indemnity cover for that activity?
Is the policy limit realistic for your exposure? A defective batch distributed across multiple hospital networks can generate claims from many parties simultaneously. The policy limit needs to reflect that possibility.
For questions about your specific regulatory obligations under the Health Products Act and HSA's recall procedures, seek advice from a Singapore-qualified lawyer with experience in health products regulation. TZY CO advises on the insurance dimension of these questions.
If you are a Singapore importer or distributor of therapeutic products and would like to understand how your current insurance programme reflects your actual exposure, we would be glad to work through it with you.
This article provides general information only. It is not insurance or legal advice. Regulatory information sourced from the Health Sciences Authority (HSA), the Health Products Act 2007, the Health Products (Therapeutic Products) Regulations 2016, and HSA's Guidance for Industry on Reporting and Recall of Defective Therapeutic Products dated 28 January 2026 (Version 3). Product liability legal framework sourced from ICLG Product Liability Laws and Regulations Singapore 2025-2026. Companies should seek qualified legal advice on their specific regulatory obligations. Policy availability, terms, conditions, and exclusions vary by insurer and product, and cover is subject to the full policy wording. Please contact TZY CO for advice on your specific situation.